MDL-102353

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMDL-102353
Drug Alias NameACE/NEP inhibitors (HMR)MDL-102353
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsEndopeptidases inhibitors
TargetsAngiotensin-converting enzymeEndopeptidases
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoechst Marion Roussel Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoechst Marion Roussel Ltd
Active IndicationsN/A
Inactive IndicationsHypertensionHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A